The Cooper Companies, Inc. (COO)

Market Cap	17.60B
Revenue (ttm)	3.31B
Net Income (ttm)	385.80M
Shares Out	49.35M
EPS (ttm)	7.76
PE Ratio	45.95
Forward PE	22.32
Dividend	$0.06 (0.02%)
Ex-Dividend Date	Jul 26, 2022

Volume	302,283
Open	349.84
Previous Close	348.93
Day's Range	347.35 - 357.52
52-Week Range	244.22 - 430.67
Beta	0.89
Analysts	Buy
Price Target	365.32 (+2.45%)
Earnings Date	Mar 2, 2023

About COO

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on fa...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 14,000
• Stock Exchange: NYSE
• Ticker Symbol: COO

Financial Performance

In 2022, COO's revenue was $3.31 billion, an increase of 13.20% compared to the previous year's $2.92 billion. Earnings were $385.80 million, a decrease of -86.90%.

Analyst Forecast

According to 21 analysts, the average rating for COO stock is "Buy." The 12-month stock price forecast is $365.32, which is an increase of 2.45% from the latest price.

Price Target

$365.32

(2.45% upside)

Analyst Consensus: Buy